November 17, 2008

Ted Grasela is awarded 2008 AAPS Fellow status

The American Association of Pharmaceutical Scientists (AAPS), at its 2008 Annual Meeting held in Atlanta, Georgia, named Ted Grasela, PharmD, PhD, a 2008 AAPS Fellow. Dr. Grasela was nominated and selected for this prestigious award based on more than 20 years of sustained remarkable scholarly and research contributions to the pharmaceutical sciences in modeling and simulation.

“The use of modeling and simulation has become an important part of the landscape of drug development and regulatory decision-making in the pharmaceutical and biotechnology industry” said Dr. Grasela. Dr. Grasela was one of the first to recognize that the successful application of modeling and simulation to improve drug development decision-making must be based, in part, on the ability to reliably meet the information needs of the development team while adhering to cost, schedule, and quality constraints.

“The application of systems engineering tools and methodologies in the design and implementation of the infrastructure for model-based drug development is critical to improving the drug development process and the health care system as a whole” said Dr. Grasela. Early on, he recognized the need to develop tools to improve documentation and archiving capabilities for model building efforts and directed the development of the PERSPECTIVE Hypertext Data Analysis Mapping tool. More recently, he has been working on efforts to improve the communication of scientific workflows among scientists across organizations and, importantly, bridge this information to healthcare providers.

Dr. Grasela was one of the early adopters of population pharmacokinetic analysis methodology, and his early collaborations with a number of pharmaceutical companies provided an understanding of the potential value of these methods in drug development. In more then 70 publications and 10 book chapters, Dr. Grasela has outlined the advantages of the population approach and the implications of model-based thinking for pharmacoepidemiology, pharmacoeconomics, and clinical pharmacology.

Thaddeus H. Grasela, PharmD, PhD is the President and Chief Executive Officer of Cognigen Corporation. He manages a group of more than 50 scientists and support staff whose primary mission is to provide modeling and simulation support for all stages of drug discovery, development, and commercialization. Dr. Grasela serves as a scientific and strategic consultant for project teams, spending a considerable amount of his time mentoring and coaching junior pharmacometricians. Dr. Grasela also directs the research program to continually improve the quality and productivity of Cognigen’s modeling and simulation efforts.

About Cognigen
Cognigen Corporation, a leading provider of pharmacometric and clinical pharmacology consulting services to the pharmaceutical and biotechnology industries, uses the tools of pharmacometrics, embedded in a highly developed enterprise infrastructure, to support decision-making at critical points
in drug development. Cognigen provides comprehensive pharmacometric analysis and support services, emphasizing pharmacokinetic and pharmacodynamic (PK/PD) modeling, statistical analyses, clinical trial simulations, and comprehensive regulatory reporting, focused on dose selection and justification decision support.

About AAPS
The AAPS is a professional, scientific society of more than 13,500 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to health. AAPS offers timely scientific programs, on-going education, information resources, and opportunities for networking and professional development. To learn more about AAPS, visit http://www.aapspharmaceutica.com.

 

You have chosen to email the article entitled:

Ted Grasela is awarded 2008 AAPS Fellow status

Your Name:     * Your Email:    *

Friends Name: * Friends Email: *

Comments:

Please enter the word you see in the image below:

*

  

* = Required Field

Commenting is not available for this article.